11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms

      review-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antimicrobial peptides are an attractive alternative to traditional antibiotics, due to their physicochemical properties, activity toward a broad spectrum of bacteria, and mode-of-actions distinct from those used by current antibiotics. In general, antimicrobial peptides kill bacteria by either disrupting their membrane, or by entering inside bacterial cells to interact with intracellular components. Characterization of their mode-of-action is essential to improve their activity, avoid resistance in bacterial pathogens, and accelerate their use as therapeutics. Here we review experimental biophysical tools that can be employed with model membranes and bacterial cells to characterize the mode-of-action of antimicrobial peptides.

          Related collections

          Most cited references103

          • Record: found
          • Abstract: found
          • Article: not found

          The antibiotic resistance crisis: part 1: causes and threats.

          Decades after the first patients were treated with antibiotics, bacterial infections have again become a threat because of the rapid emergence of resistant bacteria-a crisis attributed to abuse of these medications and a lack of new drug development.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Antimicrobial peptides of multicellular organisms.

            Multicellular organisms live, by and large, harmoniously with microbes. The cornea of the eye of an animal is almost always free of signs of infection. The insect flourishes without lymphocytes or antibodies. A plant seed germinates successfully in the midst of soil microbes. How is this accomplished? Both animals and plants possess potent, broad-spectrum antimicrobial peptides, which they use to fend off a wide range of microbes, including bacteria, fungi, viruses and protozoa. What sorts of molecules are they? How are they employed by animals in their defence? As our need for new antibiotics becomes more pressing, could we design anti-infective drugs based on the design principles these molecules teach us?
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

              Antimicrobial peptides are an abundant and diverse group of molecules that are produced by many tissues and cell types in a variety of invertebrate, plant and animal species. Their amino acid composition, amphipathicity, cationic charge and size allow them to attach to and insert into membrane bilayers to form pores by 'barrel-stave', 'carpet' or 'toroidal-pore' mechanisms. Although these models are helpful for defining mechanisms of antimicrobial peptide activity, their relevance to how peptides damage and kill microorganisms still need to be clarified. Recently, there has been speculation that transmembrane pore formation is not the only mechanism of microbial killing. In fact several observations suggest that translocated peptides can alter cytoplasmic membrane septum formation, inhibit cell-wall synthesis, inhibit nucleic-acid synthesis, inhibit protein synthesis or inhibit enzymatic activity. In this review the different models of antimicrobial-peptide-induced pore formation and cell killing are presented.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Med Technol
                Front Med Technol
                Front. Med. Technol.
                Frontiers in Medical Technology
                Frontiers Media S.A.
                2673-3129
                11 December 2020
                2020
                : 2
                : 610997
                Affiliations
                School of Biomedical Sciences, Institute of Health & Biomedical Innovation, and Translational Research Institute, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Queensland University of Technology , Brisbane, QLD, Australia
                Author notes

                Edited by: Lorenzo Stella, University of Rome Tor Vergata, Italy

                Reviewed by: Frances Separovic, The University of Melbourne, Australia; Diana Lousa, New University of Lisbon, Portugal

                *Correspondence: Sónia Troeira Henriques sonia.henriques@ 123456qut.edu.au

                This article was submitted to Pharmaceutical Innovation, a section of the journal Frontiers in Medical Technology

                Article
                10.3389/fmedt.2020.610997
                8757789
                0d4033cf-99f6-42b7-815d-8d11a7405e0b
                Copyright © 2020 Benfield and Henriques.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 28 September 2020
                : 20 November 2020
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 103, Pages: 10, Words: 7294
                Funding
                Funded by: Australian Research Council, doi 10.13039/501100000923;
                Categories
                Medical Technology
                Mini Review

                peptide-lipid interactions,bacterial membrane,cellular uptake,biophysical methodologies,peptide therapeutics

                Comments

                Comment on this article